Jean-Louis Falco
Chief Executive Officer chez CliniGenetics SA
Profil
Jean-Louis Falco is the founder of CliniGenetics SA. He is currently the Chairman at Aurex SAS and SAS Linerbenne.
Previously, he served as the Chief Executive Officer at Arteria SA (France) and as a Member-Supervisory Board at Bleecker SA. He graduated from Université Paris Dauphine-PSL.
Postes actifs de Jean-Louis Falco
| Sociétés | Poste | Début |
|---|---|---|
CliniGenetics SA
 CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Chief Executive Officer | - |
| Aurex SAS | Chairman | - |
| SAS Linerbenne | Chairman | - |
Anciens postes connus de Jean-Louis Falco
| Sociétés | Poste | Fin |
|---|---|---|
| Arteria SA (France) | Chief Executive Officer | - |
| BLEECKER | Director/Board Member | - |
Formation de Jean-Louis Falco
| Université Paris Dauphine-PSL | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BLEECKER | Finance |
| Entreprise privées | 4 |
|---|---|
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Health Technology |
| Arteria SA (France) | Commercial Services |
| Aurex SAS | |
| SAS Linerbenne |
